Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04821622
Recruitment Status : Recruiting
First Posted : March 29, 2021
Last Update Posted : May 19, 2022
Astellas Pharma Inc
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 11, 2024
Estimated Study Completion Date : April 10, 2027